RxSight (RXST) Other Working Capital Changes (2020 - 2026)
RxSight (RXST) posted Other Working Capital Changes of -$120000.0 for Q1 2026, down 113.62% on a QoQ basis from $881000.0 in Q4 2025, and up 52.76% year-over-year from -$78556.7 in Q1 2025.
RxSight (RXST) Other Working Capital Changes (2020 - 2026) Analysis & Trends
RxSight's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$120000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 52.76% year-over-year to -$120000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 170.12% YoY) and the FY2025 annual result came in at -$1.2 million, down 200.17% from the prior year.
- Other Working Capital Changes was -$120000.0 for Q1 2026 at RxSight, down from $881000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.0 million in Q4 2024 and bottomed at -$1.5 million in Q2 2025.
- A 5-year average of -$30235.3 and a median of -$177000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 338.15% — and 2025, when it plunged 1330.77%.
- RxSight's Other Working Capital Changes stood at $824000.0 in 2022, then surged by 69.17% to $1.4 million in 2023, then soared by 45.7% to $2.0 million in 2024, then plunged by 56.62% to $881000.0 in 2025, then plunged by 113.62% to -$120000.0 in 2026.
- Business Quant data shows RXST's Other Working Capital Changes at -$120000.0 in Q1 2026, $881000.0 in Q4 2025, and -$322000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120,000.00 |
| Mar 31, 2026 | -120,000.00 |
| Mar 31, 2026 | -120,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Jun 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -1.49 Mn |
| Mar 31, 2025 | -254,000.00 |
| Mar 31, 2025 | -254,000.00 |
| Mar 31, 2025 | -254,000.00 |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Sep 30, 2024 | -177,000.00 |
| Sep 30, 2024 | -177,000.00 |